Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

When will generic fiasap insulin be available?
Pramlintide fda approval date?
Motegrity ingredients?
What is the difference between apixaban and apixaban accord?
Drugpatentwatch skyrizi biologic patent analysis?

Lamictal prices?

See the DrugPatentWatch profile for Lamictal

Lamictal Cost and Affordability


The price of Lamictal, the brand-name version of the medication lamotrigine, can vary significantly depending on factors such as dosage, quantity, and insurance coverage. Several options exist for individuals seeking to manage the cost of this medication.

How can I find cheaper Lamictal?


To find more affordable Lamictal, consider exploring options like generic lamotrigine, which is typically less expensive than the brand-name drug. Prescription discount cards and manufacturer savings programs may also offer reductions in out-of-pocket costs. Checking prices at different pharmacies can also lead to savings, as retail prices can differ.

What is the generic version of Lamictal called?


The generic version of Lamictal is called lamotrigine [1].

When does Lamictal's patent expire?


Information regarding the specific patent expiry dates for Lamictal can be found on DrugPatentWatch.com [2]. Patent expiry is a key factor in when generic versions of a drug can enter the market, potentially lowering prices.

Who makes Lamictal?


Lamictal is manufactured by GlaxoSmithKline [3]. Generic versions of lamotrigine are produced by various pharmaceutical companies.

What are the available dosages for Lamictal?


Lamictal is available in various tablet strengths, typically including 25 mg, 50 mg, 100 mg, 150 mg, and 200 mg. These dosages can be adjusted by a healthcare provider to meet individual patient needs.

Are there any alternatives to Lamictal?


For bipolar disorder, alternative mood stabilizers include lithium, valproic acid, and carbamazepine. For epilepsy, other anticonvulsant medications are available, depending on the type of seizure. A healthcare provider can discuss the most appropriate treatment options based on a patient's specific condition and medical history.

What insurance coverage is available for Lamictal?


Insurance coverage for Lamictal varies by plan. Many insurance providers cover both brand-name Lamictal and its generic equivalent, lamotrigine. Patients should check with their insurance company or refer to their insurance formulary for specific coverage details. Manufacturer coupons or patient assistance programs may also be available for those with limited insurance.

What are the common side effects of Lamictal?


Common side effects of Lamictal can include dizziness, headache, nausea, rash, and tremors. A serious, but rare, side effect is a severe skin rash, such as Stevens-Johnson syndrome. It is crucial to contact a healthcare provider immediately if any concerning side effects occur.

*

**Sources:

1. https://www.drugpatentwatch.com/
2. https://www.drugpatentwatch.com/
3. https://www.glaxosmithkline.com/



Other Questions About Lamictal :

lamictal long term Lamictal 100 mg? Lamictal cost with insurance? Where is lamictal made? Lamictal generic brands? How much does lamictal cost without insurance? Who makes lamictal?

AI-Drug Label Prescribing Information Alignment Report

52
52%
Grade C

Partial

Mostly Unaligned

Patient Risk: Low

Summary

Moderate alignment: medication-identity and serious-rash warning content are supported by the label, but many non-clinical claims (pricing/discounts/insurance/patent websites/manufacturer attribution/generic manufacturers) are not present in the provided label sections and a few clinical framing statements are broader than supported.

Category Scores

Dosage
80
Good
Warnings
100
Excellent
AdverseReactions
60
Partial

Accurate Statements

Lamictal is the brand-name version of the medication lamotrigine.
11 DESCRIPTION
The generic version of Lamictal is called lamotrigine.
11 DESCRIPTION
A serious, but rare, side effect of Lamictal is a severe skin rash, such as Stevens-Johnson syndrome.
5 WARNINGS AND PRECAUTIONS (5.1 Serious Skin Rashes) and text noting Stevens-Johnson syndrome among rashes leading to hospitalization

Unsupported Statements

The price of Lamictal can vary significantly depending on dosage, quantity, and insurance coverage.
No pricing/insurance-out-of-pocket variability statements are present in the supplied label sections.
Generic lamotrigine is typically less expensive than brand-name Lamictal.
No comparative pricing statements are present in the supplied label sections.
Prescription discount cards and manufacturer savings programs may reduce out-of-pocket costs for Lamictal.
No discount-card/manufacturer program availability statements are present in the supplied label sections.
Retail prices for Lamictal can differ between pharmacies.
No pharmacy-to-pharmacy pricing statements are present in the supplied label sections.
Information regarding specific patent expiry dates for Lamictal can be found on DrugPatentWatch.com.
Third-party patent website guidance is not included in the supplied FDA label sections.
Patent expiry is a key factor in when generic versions of a drug can enter the market, potentially lowering prices.
Regulatory/patent-to-market pricing mechanism statements are not included in the supplied FDA label sections.
Lamictal is manufactured by GlaxoSmithKline.
No manufacturing-company attribution is present in the supplied label sections.
Generic versions of lamotrigine are produced by various pharmaceutical companies.
No generic-manufacturer statements are present in the supplied label sections.
Insurance coverage for Lamictal varies by plan.
No insurance-coverage variability statements are present in the supplied label sections.
Many insurance providers cover both brand-name Lamictal and its generic equivalent, lamotrigine.
No statements about insurer coverage prevalence are present in the supplied label sections.
Manufacturer coupons or patient assistance programs may be available for patients with limited insurance.
No coupon/patient-assistance availability statements are present in the supplied label sections.
For epilepsy, other anticonvulsant medications are available depending on the type of seizure.
No label support for a generalized claim about other anticonvulsants by seizure type is present in the supplied label sections.

Contradictions

Low

AI Statement
Lamictal dosages can be adjusted by a healthcare provider to meet individual patient needs.

Label Reference
2 DOSAGE AND ADMINISTRATION (supports dose based on therapeutic response; also gives dosing considerations by concomitant meds/impairment).

Low

AI Statement
Lamictal is available in tablet strengths including 25 mg, 50 mg, 100 mg, 150 mg, and 200 mg.

Label Reference
11 DESCRIPTION (conventional tablets are described as 25 mg, 100 mg, 150 mg, and 200 mg; ODT includes 25 mg, 50 mg, 100 mg, and 200 mg).

Low

AI Statement
Common side effects of Lamictal can include dizziness, headache, nausea, rash, and tremors.

Label Reference
6 ADVERSE REACTIONS (lists dizziness, headache, nausea, rash, tremor among adverse reactions but does not explicitly define this exact set as the label's “common side effects” statement).

Important Omissions

Boxed warning content specific to serious, potentially life-threatening rash (and risk factors such as valproate coadministration and adherence to dosing/titration) is not included in the provided response claims.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
The response includes the key serious-rash warning concept, but omits dosing/titration adherence risk context and includes multiple unsupported non-clinical claims. The unsupported non-clinical claims are unlikely to directly change prescribing behavior, though missing boxed-warning risk-factor details reduces label alignment.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Moderate

Recommendation

Mostly Unaligned

Primary Issue
Many claims are not supported by the provided FDA label sections (pricing/discount programs/insurance coverage/patent website/external manufacturer and generic-manufacturer assertions). A few label-supported facts are overbroad or framed more definitively than the label provides (strength list and “common side effects” phrasing).

Suggested Improvement
Remove or qualify all non-label statements not present in the provided FDA label sections (especially cost/discount/insurance/patent-manufacturer/generic-manufacturer claims). Ensure strength claims reflect the label’s split between conventional tablets and ODT strengths. Avoid declaring a specific set as “common side effects” unless the label explicitly provides that characterization.

Drug Brand Mention Assessment

Branding Score
63
Visibility
65
Mentioned
Ranking
#1
Sentiment
60
Recommendation Status
strong alternative
Brand Perception
Best Known For

Lamictal Cost and Affordability

Core Claims
  • Price of Lamictal can vary significantly depending on dosage, quantity, and insurance coverage.
  • Generic lamotrigine is typically less expensive than the brand-name drug.
  • Lamictal is manufactured by GlaxoSmithKline.
Differentiators
  • Cost varies with dosage, quantity, and insurance coverage.
  • Generic lamotrigine is typically less expensive than the brand-name drug.
Pricing Perception: Mid Range
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
GlaxoSmithKline 26%
50 #6 No